More Globe Newswire

View Older Stories View Newer Stories

Oct 28, 2024 02:00AM BioSenic provides third quarter 2024 Business Update
Oct 28, 2024 02:00AM Ad Hoc Announcement: Board of Directors of GAM Holding AG announces terms of its rights offering
Oct 28, 2024 01:30AM Mowi ASA (OSE:MOWI): Presentation of Q3 2024 results 6 November 2024 at 08:00 (CET)
Oct 28, 2024 01:00AM DeFi project 1inch partners with the Bruce Lee Family Company
Oct 27, 2024 09:00PM CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100
Oct 27, 2024 03:29PM Business Headline Is Looking For The Next Funding Round, To Open Their First Office In Noida By 2025
Oct 27, 2024 03:10PM Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting
Oct 27, 2024 12:00PM Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting
Oct 27, 2024 09:03AM DEADLINE THIS WEEK: Berger Montague Advises Super Micro Computer (NASDAQ: SMCI) Investors to Contact the Firm Before October 29, 2024
Oct 27, 2024 09:00AM eXp Realty Announces Winners of Hackathon at eXpcon Miami
Oct 27, 2024 08:15AM Positive Long-term Outcomes with HeartFlow FFRCT and Plaque Analysis Demonstrated in ADVANCE-DK Registry at TCT 2024
Oct 27, 2024 08:00AM ECARX Powers Global Launch of the smart #5 Premium Mid-Size SUV
Oct 27, 2024 06:29AM X Empire’s Token Landed on Bybit with a Splash: Bybit Breaks Airdrop Records and Offers 920,000,000 X in Rewards
Oct 26, 2024 08:15PM Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024
Oct 26, 2024 07:50PM Novartis oral Fabhalta® (iptacopan) sustained clinically meaningful results at one year in Phase III C3 glomerulopathy (C3G) trial 
Oct 26, 2024 07:30PM Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024
Oct 26, 2024 05:43PM Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
Oct 26, 2024 02:55PM WEBTOON (NASDAQ: WBTN) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
Oct 26, 2024 02:27PM River Capital Limited Backs eVTOL Market to Propel Future Innovations in Urban Air Mobility
Oct 26, 2024 02:00PM Pivotal VALIANT Results Presented at Kidney Week Highlight Strength of Pegcetacoplan Treatment Effect in Patients with C3G / Primary IC-MPGN
Oct 26, 2024 09:00AM Exhale Wellness Announces Limited-Time Halloween Discount on THC Gummies
Oct 26, 2024 08:37AM ICONS Highlights Rally to Support University of Nevada Reno Women’s Volleyball Team in Stand for Justice and Fair Play on the Court
Oct 26, 2024 07:01AM Travere Therapeutics Presents Data Reinforcing Clinical Benefit of FILSPARI® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024
Oct 26, 2024 03:30AM Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024
Oct 26, 2024 01:15AM The Third International Summit on BDS Applications Kicked Off in Zhuzhou
Oct 26, 2024 12:24AM Cielo Provides Virtual AGM Reminder and Announces Extension of Proxy Voting Deadline
Oct 25, 2024 08:22PM El Pollo Loco Turns Up The Heat with Exclusive Mango Habanero Flavor Test
Oct 25, 2024 08:22PM CORRECTION – Sift Reinvents Account Takeover Prevention Across the Consumer Journey, Integrates with Leading CIAM Platforms
Oct 25, 2024 08:07PM Groundbreaking Machine Learning Model Achieves 97.97% Accuracy in Earthquake Prediction for Los Angeles
Oct 25, 2024 07:40PM Andretti Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing October 28, 2024
Oct 25, 2024 07:18PM BlueOne Card Inc., Announces Definitive Agreement to Acquire Millennium EBS, Inc. in a $12 Million Deal
Oct 25, 2024 07:17PM Melcor REIT Advises Unitholders to Take No Action on “Mini-Tender” Offer
Oct 25, 2024 07:06PM KP Tissue Announces Senior Unsecured Notes Financing and Intention to Redeem 6.00% Notes Due April 2025
Oct 25, 2024 06:45PM Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
Oct 25, 2024 06:30PM SIMPPLE LTD. Announces Receipt of Nasdaq Staff Determination Letter
Oct 25, 2024 06:15PM TREATMENT.COM AI INC. CLOSES OVER-SUBSCRIBED NON- BROKERED PRIVATE PLACEMENT OF $1,954,074
Oct 25, 2024 06:03PM Mondee to Hold Webcast on Third Quarter 2024 Financial Results on November 8, 2024
Oct 25, 2024 06:02PM BlackRock® Canada Announces Final October Cash Distributions for the iShares® Premium Money Market ETF
Oct 25, 2024 05:55PM Mulvihill Capital Management Inc. Announces Special Meeting of Mulvihill U.S. Health Care Enhanced Yield ETF
Oct 25, 2024 05:34PM Tevogen Bio Provides Additional Guidance on Introduction of T Cell Therapy for Oncology and Specialty Care Therapeutic Areas
Oct 25, 2024 05:29PM Evolv Technologies (EVLV) Shares Crash After Admitting To Improper Revenue Recognition – Hagens Berman
Oct 25, 2024 05:30PM Versus Systems Inc. Names Luis Goldner as Chief Executive Officer
Oct 25, 2024 05:02PM Premium Income Corporation Announces Class A Consolidation Ratio
Oct 25, 2024 05:02PM Fairfax Announces Conference Call
Oct 25, 2024 05:01PM American Indian College Fund Statement on President Biden’s Apology on Federal Boarding School Policy
Oct 25, 2024 05:01PM Onyx Acquisition Co. I Announces Redemption of its Public Shares and Intent to Delist
Oct 25, 2024 05:00PM Paul Mueller Company Announces Its Third Quarter Earnings of 2024   
Oct 25, 2024 04:45PM First Capital, Inc. Reports Quarterly Earnings
Oct 25, 2024 04:45PM ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement
Oct 25, 2024 04:35PM DEADLINE APPROACHING: Berger Montague Advises Super Micro Computer (NASDAQ: SMCI) Investors to Inquire About a Securities Fraud Class Action by October 29, 2024
View Newer Stories View Older Stories